Bao Guo

No 678 Furong Road
Hefei, 230601, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Retraction Note: NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response.

Retraction Note: NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response.

Journal: BMC medicine
Published: September 20, 2025

ERRATUM: Melatonin attenuates hepatic oxidative stress by regulating the P62/LC3 autophagy pathway in PCOS.

ERRATUM: Melatonin attenuates hepatic oxidative stress by regulating the P62/LC3 autophagy pathway in PCOS.

Journal: Endocrine connections
Published: February 04, 2025

New insights into the structure domain and function of NLR family CARD domain containing 5.

New insights into the structure domain and function of NLR family CARD domain containing 5.

Journal: Cell communication and signaling : CCS
Published: September 23, 2024

Melatonin attenuates hepatic oxidative stress by regulating the P62/LC3 autophagy pathway in PCOS.

Melatonin attenuates hepatic oxidative stress by regulating the P62/LC3 autophagy pathway in PCOS.

Journal: Endocrine connections
Published: June 20, 2024

NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response.

NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response.

Journal: BMC medicine
Published: June 11, 2024

NLRC5 promotes endometrial carcinoma progression by regulating NF-κB pathway-mediated mismatch repair gene deficiency.

NLRC5 promotes endometrial carcinoma progression by regulating NF-κB pathway-mediated mismatch repair gene deficiency.

Journal: Scientific reports
Published: November 11, 2023

NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer.

NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer.

Journal: Translational oncology
Published: April 18, 2023

METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.

METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.

Journal: Biomarker research
Published: March 19, 2023

Pattern-recognition receptors in endometriosis: A narrative review.

Pattern-recognition receptors in endometriosis: A narrative review.

Journal: Frontiers in immunology
Published: February 08, 2023

Recent Insights into Noncoding RNAs in Primary Ovarian Insufficiency: Focus on Mechanisms and Treatments.

Recent Insights into Noncoding RNAs in Primary Ovarian Insufficiency: Focus on Mechanisms and Treatments.

Journal: The Journal of clinical endocrinology and metabolism
Published: September 02, 2022

Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting.

Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting.

Journal: Experimental hematology & oncology
Published: June 15, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026